Genetic associations between circulating metabolic biomarkers and lung cancer in East Asians and Europeans
暂无分享,去创建一个
[1] Y. J. Kim,et al. The contribution of common and rare genetic variants to variation in metabolic traits in 288,137 East Asians , 2022, Nature Communications.
[2] Li Jin,et al. Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. , 2022, Metabolism: clinical and experimental.
[3] V. Zuber,et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches , 2022, American journal of human genetics.
[4] Christopher D. Brown,et al. The power of genetic diversity in genome-wide association studies of lipids , 2021, Nature.
[5] M. Rivas,et al. A cross-population atlas of genetic associations for 220 human phenotypes , 2021, Nature Genetics.
[6] Ravensara S. Travillian,et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2021, The Lancet. Respiratory medicine.
[7] K. Kashfi,et al. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. , 2021, Biochemical pharmacology.
[8] W. Liang,et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. , 2021, Seminars in arthritis and rheumatism.
[9] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[10] Ross M. Fraser,et al. Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability , 2020, Nature Communications.
[11] E. Lerma,et al. LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies. , 2020, Seminars in cancer biology.
[12] Z. Shao,et al. Mendelian randomization study of inflammatory bowel disease and bone mineral density , 2020, BMC Medicine.
[13] S. Bojesen,et al. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals , 2020, Journal of Hematology & Oncology.
[14] F. Hu,et al. Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts. , 2020, Journal of the National Cancer Institute.
[15] L. Kiemeney,et al. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization , 2020, International journal of cancer.
[16] O. Hejlesen,et al. Associations between smoking, glucose metabolism and lipid levels: A cross-sectional study. , 2020, Journal of diabetes and its complications.
[17] S. Larsson,et al. Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.
[18] J. Bowden,et al. Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization , 2020, bioRxiv.
[19] T. Rohan,et al. Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[20] F. Tan,et al. Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study , 2019, International journal of cancer.
[21] Jiayi Shen,et al. Education and lung cancer: a Mendelian randomization study. , 2019, International journal of epidemiology.
[22] S. Djurovic,et al. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence , 2019, Molecular Psychiatry.
[23] Miaomei Yu,et al. Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study , 2018, Lipids in Health and Disease.
[24] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[25] Y. Liu,et al. Association of total cholesterol, low‐density lipoprotein cholesterol, and non‐high‐density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population , 2018, International journal of cancer.
[26] Xiaojing Lin,et al. Dietary Cholesterol Intake and Risk of Lung Cancer: A Meta-Analysis , 2018, Nutrients.
[27] Christian Gieger,et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.
[28] Lei Lu,et al. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. , 2017, Journal of clinical lipidology.
[29] L. Kiemeney,et al. Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study , 2017, PloS one.
[30] William S. Bush,et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes , 2017, Nature Genetics.
[31] I. Idris,et al. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review , 2016, Diabetic medicine : a journal of the British Diabetic Association.
[32] J. Manson,et al. Lipid biomarkers and long-term risk of cancer in the Women's Health Study. , 2016, The American journal of clinical nutrition.
[33] M. Hendryx,et al. Pre-existing diabetes and lung cancer prognosis , 2016, British Journal of Cancer.
[34] M. M. Rahman,et al. Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .
[35] Stephen Burgess,et al. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.
[36] S. Thompson,et al. Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.
[37] A. Tall,et al. Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.
[38] G. Davey Smith,et al. Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.
[39] C. Tseng. Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study , 2014, PloS one.
[40] L. Zelek,et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk , 2014, European Journal of Epidemiology.
[41] F. Tinahones,et al. Inflammation, oxidative stress and metabolic syndrome: dietary modulation. , 2014, Current vascular pharmacology.
[42] D. Arveiler,et al. Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[43] Juhua Luo,et al. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients. , 2012, Lung cancer.
[44] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[45] Anne Tybjærg-Hansen,et al. Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. , 2011, Journal of the National Cancer Institute.
[46] P. Stattin,et al. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study , 2011, Cancer Causes & Control.
[47] P. Stattin,et al. Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts , 2009, PLoS medicine.
[48] J. Klenk,et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria , 2009, British Journal of Cancer.
[49] T. Trikalinos,et al. Statins, low-density lipoprotein cholesterol, and risk of cancer. , 2008, Journal of the American College of Cardiology.
[50] C. Roberts,et al. Diabetes and the risk of lung cancer. , 2005, Diabetes care.
[51] J. Samet,et al. Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.
[52] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..